Natalie C Dosch1, Elyssa F Guslits1, Morgan B Weber1, Shannon E Murray1, Barbara Ha1, Christopher L Coe2, Anthony P Auger3, Pamela J Kling4. 1. Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin, Madison, WI. 2. Harlow Center for Biological Psychology, University of Wisconsin, Madison, WI; Department of Psychology, University of Wisconsin, Madison, WI. 3. Department of Psychology, University of Wisconsin, Madison, WI. 4. Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin, Madison, WI. Electronic address: pkling@pediatrics.wisc.edu.
Abstract
OBJECTIVE: To determine the impact of maternal obesity and gestational weight gain across pregnancy on fetal indices of inflammation and iron status. STUDY DESIGN: Eighty-five healthy term newborns delivered via elective cesarean were categorized by 2 maternal body mass index (BMI) thresholds; above or below 30 kg/m(2) or above or below 35 kg/m(2). Umbilical cord plasma levels of C-reactive protein, interleukin (IL)-6, tumor necrosis factor (TNF)-α, ferritin, and hepcidin were assayed. Cytokines released by phytohemagglutinin-stimulated umbilical cord mononuclear cells (MNCs) were assayed. RESULTS: Maternal class II obesity, defined as BMI of 35 kg/m(2) and above, predicted higher C-reactive protein and TNF-α in umbilical cord plasma (P < .05 for both), and also proinflammatory cytokines (IL-1β, IL-6, and TNF-α) from stimulated MNC (P < .05 for all). The rise in plasma TNF-α and MNC TNF-α was not linear but occurred when the threshold of BMI 35 kg/m(2) was reached (P < .005, P < .06). Poorer umbilical cord iron indices were associated with maternal obesity. When ferritin was low, IL-6 was higher (P < .04), but this relationship was present primarily when maternal BMI exceeded 35 kg/m(2) (P < .03). Ferritin was correlated with hepcidin (P < .0001), but hepcidin was unrelated to either maternal BMI or inflammatory indices. CONCLUSIONS: Class II obesity and above during pregnancy is associated with fetal inflammation in a threshold fashion. Although maternal BMI negatively impacted fetal iron status, hepcidin, related to obesity in adults, was related to iron status and not obesity in fetuses. Pediatricians should be aware of these relationships.
OBJECTIVE: To determine the impact of maternal obesity and gestational weight gain across pregnancy on fetal indices of inflammation and iron status. STUDY DESIGN: Eighty-five healthy term newborns delivered via elective cesarean were categorized by 2 maternal body mass index (BMI) thresholds; above or below 30 kg/m(2) or above or below 35 kg/m(2). Umbilical cord plasma levels of C-reactive protein, interleukin (IL)-6, tumor necrosis factor (TNF)-α, ferritin, and hepcidin were assayed. Cytokines released by phytohemagglutinin-stimulated umbilical cord mononuclear cells (MNCs) were assayed. RESULTS:Maternal class II obesity, defined as BMI of 35 kg/m(2) and above, predicted higher C-reactive protein and TNF-α in umbilical cord plasma (P < .05 for both), and also proinflammatory cytokines (IL-1β, IL-6, and TNF-α) from stimulated MNC (P < .05 for all). The rise in plasma TNF-α and MNC TNF-α was not linear but occurred when the threshold of BMI 35 kg/m(2) was reached (P < .005, P < .06). Poorer umbilical cord iron indices were associated with maternal obesity. When ferritin was low, IL-6 was higher (P < .04), but this relationship was present primarily when maternal BMI exceeded 35 kg/m(2) (P < .03). Ferritin was correlated with hepcidin (P < .0001), but hepcidin was unrelated to either maternal BMI or inflammatory indices. CONCLUSIONS:Class II obesity and above during pregnancy is associated with fetal inflammation in a threshold fashion. Although maternal BMI negatively impacted fetal iron status, hepcidin, related to obesity in adults, was related to iron status and not obesity in fetuses. Pediatricians should be aware of these relationships.
Authors: Marilyn Halonen; I Carla Lohman; Debra A Stern; Whitney L Ellis; Janet Rothers; Anne L Wright Journal: Am J Respir Crit Care Med Date: 2013-07-01 Impact factor: 21.405
Authors: Nipun Saini; Kaylee K Helfrich; Sze Ting Cecilia Kwan; Shane M Huebner; Juna Abazi; George R Flentke; Sharon E Blohowiak; Pamela J Kling; Susan M Smith Journal: Alcohol Clin Exp Res Date: 2019-10-08 Impact factor: 3.455
Authors: Timothy M Bahr; Ashley E Benson; Pamela J Kling; Robin K Ohls; Diane M Ward; Robert D Christensen Journal: J Perinatol Date: 2021-02-16 Impact factor: 3.225